Hope for the Caregiver

Aging In Place - Transition Services

One of our newest sponsors, Sara Beth Warne heads a team of specialists to help YOU and your loved one deal with the nuances of the home.  With a lengthy background in design, Sara Beth's team KNOWS how to help make the home a safer, warmer, and more comfortable place for your loved one.  

If a move is needed, her team will inventory EVERYTHING ...so that not only are your precious loved ones cared for, but their precious things accumulated over a lifetime are cared for as well.

How often do you move?  Couple of times?  Sara Beth and her team at Aging in Place Transition Services do this EVERY DAY!  

Make it easy on yourself and those you love.  Call them today 615 330 9918

Indisputable Evidence of God's Faithfulness

Part one of my conversation with Ken Tada  - Husband of Joni Eareckson-Tada.  Ken and Joni shine as indisputable evidence of God's faithfulness.

As a caregiving husband of 32 years for Joni (who suffers from quadriplegia), Ken brings an astonishing understanding of God's provision, faithfulness, and wisdom.

BOOK RELEASED 9/16/2014

He DOES look like Bill Clinton

Couple of funny stories and a Bill Clinton impression!

Don't Do This Alone

The Isolation we caregivers often live in leads us to make poor decisions.  It's a lonely walk, but don't do this alone.  

Where no counsel is, the people fall: but in the multitude of counselors there is safety. 

Proverbs 11:14

For a caregiver, that multitude of counselors contain:

• Pastors
• Physicians
• Accountant
• Financial Planner
• Therapist
• Trusted CLOSE friends

Alzheimer's vs. Dementia

Part 3 of my interview with Daniel Claasen, MD 

Dr. Daniel Claassen is an Assistant Professor of Neurology at Vanderbilt University and a neurologist specializing in the care of patients with neurodegenerative disorders, with particular interest in patients with cognitive dysfunction and movement disorders. He earned his medical degree from the Medical College of Georgia and completed his Neurology residency training at the Mayo Clinic, in Rochester, MN and postdoctoral training at the University of Virginia, in Charlottesville, VA. He is a past recipient of the American Academy of Neurology clinical research training grant. Dr. Claassen’s research focuses on understanding brain-behavior relationships in the context of the diagnosis and treatment of neurodegenerative diseases.

Since 2009, he has focused his research efforts on behavioral studies in neurodegenerative disorders, evaluating the influence of medications on behavior and cognition. His current studies address cognitive changes that account for impulsive compulsive behaviors. Furthermore, he maintains an active clinical and research interest in the utility of functional neuroimaging. Clinically, his expertise in FDG PET quantitation enables improved recognition and diagnostic certainty of neurodegenerative disorders, such as Alzheimer’s disease

.

Parkinson's Disease

Part 2 of my interview with Daniel Claasen, MD 

Dr. Daniel Claassen is an Assistant Professor of Neurology at Vanderbilt University and a neurologist specializing in the care of patients with neurodegenerative disorders, with particular interest in patients with cognitive dysfunction and movement disorders. He earned his medical degree from the Medical College of Georgia and completed his Neurology residency training at the Mayo Clinic, in Rochester, MN and postdoctoral training at the University of Virginia, in Charlottesville, VA. He is a past recipient of the American Academy of Neurology clinical research training grant. Dr. Claassen’s research focuses on understanding brain-behavior relationships in the context of the diagnosis and treatment of neurodegenerative diseases.

Since 2009, he has focused his research efforts on behavioral studies in neurodegenerative disorders, evaluating the influence of medications on behavior and cognition. His current studies address cognitive changes that account for impulsive compulsive behaviors. Furthermore, he maintains an active clinical and research interest in the utility of functional neuroimaging. Clinically, his expertise in FDG PET quantitation enables improved recognition and diagnostic certainty of neurodegenerative disorders, such as Alzheimer’s disease

.

Huntington's Disease

Do you or a loved one deal with Huntington's disease?

This is part one of my interview with Dr. Daniel Claassen, asst. professor of Neurology, Vanderbilt University.

Dr. Daniel Claassen is an Assistant Professor of Neurology at Vanderbilt University and a neurologist specializing in the care of patients with neurodegenerative disorders, with particular interest in patients with cognitive dysfunction and movement disorders. He earned his medical degree from the Medical College of Georgia and completed his Neurology residency training at the Mayo Clinic, in Rochester, MN and postdoctoral training at the University of Virginia, in Charlottesville, VA. He is a past recipient of the American Academy of Neurology clinical research training grant. Dr. Claassen’s research focuses on understanding brain-behavior relationships in the context of the diagnosis and treatment of neurodegenerative diseases.

Since 2009, he has focused his research efforts on behavioral studies in neurodegenerative disorders, evaluating the influence of medications on behavior and cognition. His current studies address cognitive changes that account for impulsive compulsive behaviors. Furthermore, he maintains an active clinical and research interest in the utility of functional neuroimaging. Clinically, his expertise in FDG PET quantitation enables improved recognition and diagnostic certainty of neurodegenerative disorders, such as Alzheimer’s disease